List of Tables
    Table 1. Global Anti-Infective Drugs Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
    Table 2. Global Anti-Infective Drugs Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
    Table 3. Global Anti-Infective Drugs Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Anti-Infective Drugs Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Anti-Infective Drugs Sales (K Units) of Key Manufacturers (2017-2022)
    Table 6. Global Anti-Infective Drugs Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Anti-Infective Drugs Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Anti-Infective Drugs Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Anti-Infective Drugs Average Price (USD/Unit) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Anti-Infective Drugs Manufacturing Sites and Area Served
    Table 11. Manufacturers Anti-Infective Drugs Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Anti-Infective Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Infective Drugs as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Anti-Infective Drugs Sales by Region (2017-2022) & (K Units)
    Table 16. Global Anti-Infective Drugs Sales Market Share by Region (2017-2022)
    Table 17. Global Anti-Infective Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Anti-Infective Drugs Revenue Market Share by Region (2017-2022)
    Table 19. North America Anti-Infective Drugs Sales by Country (2017-2022) & (K Units)
    Table 20. North America Anti-Infective Drugs Sales Market Share by Country (2017-2022)
    Table 21. North America Anti-Infective Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Anti-Infective Drugs Revenue Market Share by Country (2017-2022)
    Table 23. Europe Anti-Infective Drugs Sales by Country (2017-2022) & (K Units)
    Table 24. Europe Anti-Infective Drugs Sales Market Share by Country (2017-2022)
    Table 25. Europe Anti-Infective Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Anti-Infective Drugs Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Anti-Infective Drugs Sales by Region (2017-2022) & (K Units)
    Table 28. Asia Pacific Anti-Infective Drugs Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Anti-Infective Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Anti-Infective Drugs Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Anti-Infective Drugs Sales by Country (2017-2022) & (K Units)
    Table 32. Latin America Anti-Infective Drugs Sales Market Share by Country (2017-2022)
    Table 33. Latin America Anti-Infective Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Anti-Infective Drugs Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Anti-Infective Drugs Sales by Country (2017-2022) & (K Units)
    Table 36. Middle East and Africa Anti-Infective Drugs Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Anti-Infective Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Anti-Infective Drugs Revenue Market Share by Country (2017-2022)
    Table 39. Global Anti-Infective Drugs Sales by Type (2017-2022) & (K Units)
    Table 40. Global Anti-Infective Drugs Sales Market Share by Type (2017-2022)
    Table 41. Global Anti-Infective Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Anti-Infective Drugs Revenue Share by Type (2017-2022)
    Table 43. Global Anti-Infective Drugs Price by Type (2017-2022) & (USD/Unit)
    Table 44. Global Anti-Infective Drugs Sales (K Units) by Application (2017-2022)
    Table 45. Global Anti-Infective Drugs Sales Market Share by Application (2017-2022)
    Table 46. Global Anti-Infective Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Anti-Infective Drugs Revenue Share by Application (2017-2022)
    Table 48. Global Anti-Infective Drugs Price by Application (2017-2022) & (USD/Unit)
    Table 49. GlaxoSmithKline Corporation Information
    Table 50. GlaxoSmithKline Description and Business Overview
    Table 51. GlaxoSmithKline Anti-Infective Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 52. GlaxoSmithKline Anti-Infective Drugs Product
    Table 53. GlaxoSmithKline Recent Developments/Updates
    Table 54. Merck Corporation Information
    Table 55. Merck Description and Business Overview
    Table 56. Merck Anti-Infective Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 57. Merck Anti-Infective Drugs Product
    Table 58. Merck Recent Developments/Updates
    Table 59. Pfizer Corporation Information
    Table 60. Pfizer Description and Business Overview
    Table 61. Pfizer Anti-Infective Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 62. Pfizer Anti-Infective Drugs Product
    Table 63. Pfizer Recent Developments/Updates
    Table 64. Novartis AG Corporation Information
    Table 65. Novartis AG Description and Business Overview
    Table 66. Novartis AG Anti-Infective Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 67. Novartis AG Anti-Infective Drugs Product
    Table 68. Novartis AG Recent Developments/Updates
    Table 69. Gilead Sciences Corporation Information
    Table 70. Gilead Sciences Description and Business Overview
    Table 71. Gilead Sciences Anti-Infective Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 72. Gilead Sciences Anti-Infective Drugs Product
    Table 73. Gilead Sciences Recent Developments/Updates
    Table 74. Abbott Corporation Information
    Table 75. Abbott Description and Business Overview
    Table 76. Abbott Anti-Infective Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 77. Abbott Anti-Infective Drugs Product
    Table 78. Abbott Recent Developments/Updates
    Table 79. Wyeth Corporation Information
    Table 80. Wyeth Description and Business Overview
    Table 81. Wyeth Anti-Infective Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 82. Wyeth Anti-Infective Drugs Product
    Table 83. Wyeth Recent Developments/Updates
    Table 84. Sanofi-Aventis Corporation Information
    Table 85. Sanofi-Aventis Description and Business Overview
    Table 86. Sanofi-Aventis Anti-Infective Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 87. Sanofi-Aventis Anti-Infective Drugs Product
    Table 88. Sanofi-Aventis Recent Developments/Updates
    Table 89. Bristol-Myers Squibb Corporation Information
    Table 90. Bristol-Myers Squibb Description and Business Overview
    Table 91. Bristol-Myers Squibb Anti-Infective Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 92. Bristol-Myers Squibb Anti-Infective Drugs Product
    Table 93. Bristol-Myers Squibb Recent Developments/Updates
    Table 94. Johnson Corporation Information
    Table 95. Johnson Description and Business Overview
    Table 96. Johnson Anti-Infective Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 97. Johnson Anti-Infective Drugs Product
    Table 98. Johnson Recent Developments/Updates
    Table 99. Roche Pharma AG Corporation Information
    Table 100. Roche Pharma AG Description and Business Overview
    Table 101. Roche Pharma AG Anti-Infective Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 102. Roche Pharma AG Anti-Infective Drugs Product
    Table 103. Roche Pharma AG Recent Developments/Updates
    Table 104. Nanosphere Corporation Information
    Table 105. Nanosphere Description and Business Overview
    Table 106. Nanosphere Anti-Infective Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 107. Nanosphere Anti-Infective Drugs Product
    Table 108. Nanosphere Recent Developments/Updates
    Table 109. NanoViricides Corporation Information
    Table 110. NanoViricides Description and Business Overview
    Table 111. NanoViricides Anti-Infective Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 112. NanoViricides Anti-Infective Drugs Product
    Table 113. NanoViricides Recent Developments/Updates
    Table 114. Novabay Pharmaceuticals Corporation Information
    Table 115. Novabay Pharmaceuticals Description and Business Overview
    Table 116. Novabay Pharmaceuticals Anti-Infective Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 117. Novabay Pharmaceuticals Anti-Infective Drugs Product
    Table 118. Novabay Pharmaceuticals Recent Developments/Updates
    Table 119. Obetech Corporation Information
    Table 120. Obetech Description and Business Overview
    Table 121. Obetech Anti-Infective Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 122. Obetech Anti-Infective Drugs Product
    Table 123. Obetech Recent Developments/Updates
    Table 124. Optimer Pharmaceuticals Corporation Information
    Table 125. Optimer Pharmaceuticals Description and Business Overview
    Table 126. Optimer Pharmaceuticals Anti-Infective Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 127. Optimer Pharmaceuticals Anti-Infective Drugs Product
    Table 128. Optimer Pharmaceuticals Recent Developments/Updates
    Table 129. Basilea Pharmaceutica AG Corporation Information
    Table 130. Basilea Pharmaceutica AG Description and Business Overview
    Table 131. Basilea Pharmaceutica AG Anti-Infective Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 132. Basilea Pharmaceutica AG Anti-Infective Drugs Product
    Table 133. Basilea Pharmaceutica AG Recent Developments/Updates
    Table 134. Daiichi Sankyo Corporation Information
    Table 135. Daiichi Sankyo Description and Business Overview
    Table 136. Daiichi Sankyo Anti-Infective Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 137. Daiichi Sankyo Anti-Infective Drugs Product
    Table 138. Daiichi Sankyo Recent Developments/Updates
    Table 139. MerLion Pharma Corporation Information
    Table 140. MerLion Pharma Description and Business Overview
    Table 141. MerLion Pharma Anti-Infective Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 142. MerLion Pharma Anti-Infective Drugs Product
    Table 143. MerLion Pharma Recent Developments/Updates
    Table 144. Theravance Corporation Information
    Table 145. Theravance Description and Business Overview
    Table 146. Theravance Anti-Infective Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 147. Theravance Anti-Infective Drugs Product
    Table 148. Theravance Recent Developments/Updates
    Table 149. Production Base and Market Concentration Rate of Raw Material
    Table 150. Key Suppliers of Raw Materials
    Table 151. Anti-Infective Drugs Distributors List
    Table 152. Anti-Infective Drugs Customers List
    Table 153. Anti-Infective Drugs Market Trends
    Table 154. Anti-Infective Drugs Market Drivers
    Table 155. Anti-Infective Drugs Market Challenges
    Table 156. Anti-Infective Drugs Market Restraints
    Table 157. Global Anti-Infective Drugs Sales Forecast by Type (2023-2028) & (K Units)
    Table 158. Global Anti-Infective Drugs Sales Market Share Forecast by Type (2023-2028)
    Table 159. Global Anti-Infective Drugs Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 160. Global Anti-Infective Drugs Revenue Market Share Forecast by Type (2023-2028)
    Table 161. Global Anti-Infective Drugs Sales Forecast by Application (2023-2028) & (K Units)
    Table 162. Global Anti-Infective Drugs Sales Market Share Forecast by Application (2023-2028)
    Table 163. Global Anti-Infective Drugs Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 164. Global Anti-Infective Drugs Revenue Market Share Forecast by Application (2023-2028)
    Table 165. Global Anti-Infective Drugs Sales Forecast by Region (2023-2028) & (K Units)
    Table 166. Global Anti-Infective Drugs Sales Market Share Forecast by Region (2023-2028)
    Table 167. Global Anti-Infective Drugs Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 168. Global Anti-Infective Drugs Revenue Market Share Forecast by Region (2023-2028)
    Table 169. Research Programs/Design for This Report
    Table 170. Key Data Information from Secondary Sources
    Table 171. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Anti-Infective Drugs
    Figure 2. Global Anti-Infective Drugs Market Share by Type in 2021 & 2028
    Figure 3. OTC Product Picture
    Figure 4. Rx Drugs Product Picture
    Figure 5. Global Anti-Infective Drugs Market Share by Application in 2021 & 2028
    Figure 6. Hospital
    Figure 7. Drugs Store
    Figure 8. Other
    Figure 9. Global Anti-Infective Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 10. Global Anti-Infective Drugs Market Size (2017-2028) & (US$ Million)
    Figure 11. Global Anti-Infective Drugs Sales (2017-2028) & (K Units)
    Figure 12. Anti-Infective Drugs Sales Share by Manufacturers in 2021
    Figure 13. Global Anti-Infective Drugs Revenue Share by Manufacturers in 2021
    Figure 14. The Global 5 and 10 Largest Anti-Infective Drugs Players: Market Share by Revenue in 2021
    Figure 15. Anti-Infective Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 16. Global Anti-Infective Drugs Sales Market Share by Region (2017-2022)
    Figure 17. Global Anti-Infective Drugs Sales Market Share by Region in 2021
    Figure 18. Global Anti-Infective Drugs Revenue Market Share by Region (2017-2022)
    Figure 19. Global Anti-Infective Drugs Revenue Market Share by Region in 2021
    Figure 20. the United States Anti-Infective Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 21. Canada Anti-Infective Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 22. Germany Anti-Infective Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 23. France Anti-Infective Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. UK Anti-Infective Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. Italy Anti-Infective Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. Russia Anti-Infective Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. China Anti-Infective Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. Japan Anti-Infective Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. South Korea Anti-Infective Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. India Anti-Infective Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. Australia Anti-Infective Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. China Taiwan Anti-Infective Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. Indonesia Anti-Infective Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Thailand Anti-Infective Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Malaysia Anti-Infective Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Mexico Anti-Infective Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Brazil Anti-Infective Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Argentina Anti-Infective Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Turkey Anti-Infective Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Saudi Arabia Anti-Infective Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. UAE Anti-Infective Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Sales Market Share of Anti-Infective Drugs by Type (2017-2022)
    Figure 43. Manufacturing Cost Structure of Anti-Infective Drugs
    Figure 44. Manufacturing Process Analysis of Anti-Infective Drugs
    Figure 45. Anti-Infective Drugs Industrial Chain Analysis
    Figure 46. Channels of Distribution
    Figure 47. Distributors Profiles
    Figure 48. Bottom-up and Top-down Approaches for This Report
    Figure 49. Data Triangulation
    Figure 50. Key Executives Interviewed